Positive immunomagnetic CD34+ cell selection in haplo-identical transplants in β-thalassemia patients: Removal of platelets using an automated system

Cytotherapy

Volumn 12, Issue 1, 2010, Pages 60-66

  Zinno, Francesco ^a   Landi, Fabiola ^a   Aureli, Viviana ^a   Balduino, Geppina ^a   Lanti, Alessandro ^b   Sodani, Pietro ^c   Adorno, Gaspare ^b   Lucarelli, Guido ^c   Isacchi, Giancarlo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c Mediterranean Institute of Hematology   (Italy)

Author keywords

Fithalassemia; Graft versus host disease; Immunomagnetic selection

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOMATION; BETA THALASSEMIA; CD34 SELECTION; CHILD; CLINICAL ARTICLE; DEVICE; FEMALE; HAPLOIDY; HUMAN; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; LEUKAPHERESIS; MALE; MICROBIAL CONTAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL TRANSPLANTATION; THROMBOCYTE;

EID: 75449113207     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653240903348301     Document Type: Article

References (20)

1. Voso MT, Hohaus S, Moos M, Pforsich M, Cremer FW, Schlenk RF, et al. Autografting with CD34- peripheral blood stem cells: retained engraftment capability and reduced tumour cell content. Br J Haematol 1999;104: 382-391
2. Bruno A, Caravita T, Adorno G, Del Poeta G, Venditti A, Stasi R, et al. Positive selection of CD34- cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors. Transfus Apher Sci 2002; 26:103-110
3. Braakman E, Schuurhuis GJ, Preijers FW, Voermans C, Theunissen K, van Riet I, et al. Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products. Cytotherapy 2008;10:83-89
4. Dykes JH, Toporski J, Juliusson G, Bekassy AN, Lenhoff S, Lindmark A, et al. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults. Transfusion 2007;47:2134-2142
5. Comoli P, Basso S, Zecca M, Pagliara D, Baldanti F, Bernardo ME, et al. Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant 2007;7:1648-1655
6. Stainer CJ, Miflin G, Anderson S, Davy B, McQuaker IG, Russell NH. A comparison of two different systems for CD34- selection of autologous or allogeneic PBSC collections. J Hematother 1998;7:375-383
7. O'Donnell PV, Myers B, Edwards J, Loper K, Rhubart P, Noga SJ. CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts. Cytotherapy 2001;3:483-488
8. Watts MJ, Somervaille TC, Ings SJ, Ahmed F, Khwaja A, Yong K, et al. Variable product purity and functional capacity after CD34 selection: a direct comparison of the Clini- MACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol 2002;118:117-123
9. Zinno F, Landi F, Aureli V, Donfrancesco A, Isacchi G. Immunomagnetic selection of progenitor cells from peripheral blood after thawing with an automatic system in a pediatric patient with a neuroblastoma. Transfusion 2008;48: 550-552
10. Arpaci F, Cetin T, Ozet A, Oysul K, Pekel A, Ataergin S, et al. The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS. J Clin Apher 2004;19:197-201.
11. Perseghin P, Gaipa G, Dassi M, Belotti D, Pogliani EM, Pioltelli P, et al. CD34- stem cell recovery after positive selection of 'overloaded' immunomagnetic columns. Stem Cells Dev 2005;14:740-743
12. Del Fante C, Perotti C, Viarengo G, Bergamaschi P, Tinelli C, Bellotti L, et al. Immunomagnetic cell selection performed for HLA haploidentical transplants with the CliniMACS device: effect of additional platelet removal on CD34- cell recovery. Stem Cells Dev 2005;14:734-739
13. Gaziev J, Sodani P, Lucarelli G. Hematopoietic stem cell transplantation in thalassemia. Bone Marrow Transplant 2008;42(Suppl 1):S41. DOI: 10.1038/bmt.2008.112.
14. Sodani P, Gaziev D, Polchi P, Erer B, Giardini C, Angelucci E, et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004;15;104:1201-1203
15. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008;22:53-63.16.
16. Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, et al. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34--selected peripheral blood progenitor cells. Stem Cells 2007;25: 228-235
17. Huang XJ. Current status of haploidentical stem cell transplantation for leukemia. J Hematol Oncol 2008; 1:27. DOI: 10.1186/1756-8722-1-27.
18. Luo XH, Chang YJ, Xu LP, Liu DH, Liu KY, Huang XJ. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT. Bone Marrow Transplant 2009;43:29-36.
19. Koh LP, Rizzieri DA, Chao NJ. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. Biol Blood Marrow Transplant 2007;3:1249-1267
20. Dey BR, Spitzer TR. Current status of haploidentical stem cell transplantation. Br J Haematol 2006;135:423-437